<DOC>
	<DOCNO>NCT00004382</DOCNO>
	<brief_summary>OBJECTIVES : I . Compare effectiveness single dose tin mesoporphyrin special blue light phototherapy control hyperbilirubinemia premature newborn Greece . II . Evaluate dose tin mesoporphyrin sufficient alleviate need phototherapy without adverse effect newborn .</brief_summary>
	<brief_title>Phase II Study Tin Mesoporphyrin v Phototherapy Hyperbilirubinemia Premature Newborns</brief_title>
	<detailed_description>PROTOCOL OUTLINE : Patients randomly assign clinical group within 96 hour birth . Patients stratify gestational age , clinical status , age treatment . One group receive tin mesoporphyrin . Patients cross phototherapy plasma bilirubin concentration reach treatment threshold . The second group receive phototherapy Special Blue fluorescent lamps least 24 hour . Patients receive second phototherapy course plasma bilirubin concentration reach treatment threshold within 24 hour first course .</detailed_description>
	<mesh_term>Hyperbilirubinemia</mesh_term>
	<mesh_term>Tin mesoporphyrin</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Premature infants gestational age 210 251 day No blood group isoimmunization ( direct Coombs ' positive ) , e.g. , rhesus ABO No glucose6phosphate dehydrogenase deficiency Prior/Concurrent Therapy No maternal phenobarbital last month pregnancy Patient Characteristics Renal : No congenital renal abnormality Cardiovascular : No congenital heart abnormality Pulmonary : No asphyxia require assist ventilation delivery Other : No major congenital abnormality , i.e . : Central nervous system Chromosomal Gastrointestinal No evident suspect congenital infection , i.e . : Cytomegalovirus Herpes Rubella Syphilis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>24 Hours</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>hematologic disorder</keyword>
	<keyword>hyperbilirubinemia</keyword>
	<keyword>rare disease</keyword>
</DOC>